MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

29 Oct 2024 Evaluate
Revenue showed a marginal decline at Rs. 323.32 millions. For the quarter ended September 2024, as compared to corresponding quarter of last year.The Net proft of the company remain more or less same to Rs. 64.16  millions from Rs. 65.55 millions ,decline by -2.12%.Operating profit for the quarter ended September 2024 rose to 114.98 millions as compared to 100.30 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 323.32 334.15 -3.24 571.12 602.50 -5.21 1258.95 913.58 37.80
Other Income 1.88 8.05 -76.65 7.33 11.25 -34.84 30.67 7.17 327.75
PBIDT 114.98 100.30 14.64 201.67 172.62 16.83 448.77 241.60 85.75
Interest 4.28 0.12 3466.67 7.44 0.46 1517.39 5.98 1.80 232.22
PBDT 110.70 100.18 10.50 194.23 172.16 12.82 442.79 239.80 84.65
Depreciation 24.24 14.09 72.04 44.42 24.20 83.55 61.10 37.42 63.28
PBT 86.46 86.09 0.43 149.81 147.96 1.25 381.69 202.38 88.60
TAX 22.30 20.54 8.57 39.13 37.01 5.73 100.52 50.53 98.93
Deferred Tax -0.14 0.70 -120.00 0.14 0.89 -84.27 6.74 -2.84 -337.32
PAT 64.16 65.55 -2.12 110.68 110.95 -0.24 281.17 151.85 85.16
Equity 128.43 123.09 4.34 128.43 125.69 2.18 125.83 121.07 3.93
PBIDTM(%) 35.56 30.02 18.48 35.31 28.65 23.25 35.65 26.45 34.79
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..